Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Shares of Chinese artificial intelligence start-up MiniMax Group surged on their Hong Kong debut on Friday, reflecting investor confidence after securing substantial support from global institutional ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

MiniMax plans to price its Hong Kong initial public offering at the top of the marketed range, people familiar with the matter said, reflecting investor enthusiasm for Chinese startups that are ...

Chinese AI company MiniMax is expected to price its Hong Kong IPO at the top of its range and raise about $538M, Reuters reported, citing three people familiar with the matter. At the higher end, the ...

MiniMax is set to raise at least HK$4.2 billion (US$537.7 million) by pricing its Hong Kong initial public offering (IPO) at the top of its marketed range, underscoring strong demand for China's ...

eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...

HONG KONG/SINGAPORE, Jan 5 (Reuters) - MiniMax Group is expected to price its Hong Kong IPO at the top of a marketing range and raise $538 million, three people with knowledge of the deal said, in the ...

Shanghai-based AI company MiniMax closed 109.9 percent higher at HK$345 per share in Hong Kong on Jan 9, raising its total market value to HK$106.7 billion on its initial public offering. [Photo ...

Two of China’s largest generative AI startups are set for back-to-back debuts in Hong Kong this week, testing investor appetite for an industry that blossomed in the post-ChatGPT era. Yet Zhipu and ...